CONCORD BIOTECH
Back to Balance Sheet
|
CONCORD BIOTECH Last 5 Year Total Liabilities History
[Consolidated]
| Mar2025 | Mar2024 | Mar2023 | Mar2022 | Mar2021 | |
|---|---|---|---|---|---|
| Total Liabilities | ₹2,034 Cr | ₹1,701 Cr | ₹1,514 Cr | ₹1,502 Cr | ₹1,313 Cr |
What is the latest Total Liabilities ratio of CONCORD BIOTECH ?
| Year | Total Liabilities |
|---|---|
| Mar2025 | ₹2,034 Cr |
| Mar2024 | ₹1,701 Cr |
| Mar2023 | ₹1,514 Cr |
| Mar2022 | ₹1,502 Cr |
| Mar2021 | ₹1,313 Cr |
How is Total Liabilities of CONCORD BIOTECH Trending?
| Years | Total Liabilities | % Change | |
|---|---|---|---|
| Mar2025 | ₹2,034 Cr | 19.61 | |
| Mar2024 | ₹1,701 Cr | 12.33 | |
| Mar2023 | ₹1,514 Cr | 0.81 | |
| Mar2022 | ₹1,502 Cr | 14.41 | |
| Mar2021 | ₹1,313 Cr | - | |
Compare Total Liabilities of peers of CONCORD BIOTECH
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| CONCORD BIOTECH | ₹14,095.9 Cr | 2% | -2.3% | -40.3% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹400,497.0 Cr | -3.5% | -6.4% | -2.6% | Stock Analytics | |
| DIVIS LABORATORIES | ₹165,492.0 Cr | -5.8% | -1.6% | 10.9% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹136,013.0 Cr | 1.4% | 7% | 23.7% | Stock Analytics | |
| CIPLA | ₹112,922.0 Cr | -4.7% | -6.8% | -0.3% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹98,115.0 Cr | -2.8% | -8.1% | -11.1% | Stock Analytics | |
CONCORD BIOTECH Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| CONCORD BIOTECH | 2% |
-2.3% |
-40.3% |
| SENSEX | -0.7% |
-1.9% |
8% |
You may also like the below Video Courses